KUALA LUMPUR: Sunway Healthcare Holdings Bhd remains positive about its prospects for the financial year 2026 after registering broad-based growth across its hospital network, improved operating leverage and rising contributions from its newer hospitals.
The healthcare group posted a net profit of RM78.16mil for the second quarter of financial year ended June 30, 2026 (2Q26), as compared to RM41.39mil in the same quarter in 2025.
Cumulative earnings over the six-month period came to RM111.49mil as compared to RM80.14mil in the first half of financial year 2025 (1H25).
Second-quarter revenue meanwhile rose to RM672.9mil, from RM518.58mil in the previous comparative quarter as contributions accelerated across all the group’s hospitals following the seasonally soft first quarter.
The group’s 1H26 revenue rose to RM1.26bil from RM992.62mil in 1H25.
According to the group, its flagship Sunway Medical Centre (SMC) Sunway City remained the principal revenue and earnings contributor, while its mature hospitals, SMC Velocity and SMC Penang, continued to benefit from stronger patient activities and revenue intensity.
“SMC Damansara and SMC Ipoh, which are the newly operational hospitals, continued to scale as their combined revenue contribution reached 11% as compared to 5% in 2Q25, as both hospitals progressed further into positive earnings before interest, taxes, depreciation and amortisation contribution,” it said.
Foreign patient revenue remained the group’s key growth pillar, rising 31% year-on-year (y-o-y), mainly on patient inflows from Indonesia, China and Cambodia. Local patient revenue grew 30% y-o-y.
Total licensed beds expanded 13% y-o-y to 1,855 beds.
As at June 30, 2026, the group had total bed capacity of 2,072 beds, providing further headroom for near‑term growth.
Bed occupancy meanwhile increased 73% from 67% in the year earlier, as inpatient admissions increased 19% y-o-y to 32,599.
The group said it is moving into 2H26 with stronger earnings momentum and a more balanced contribution across its portfolio.
While acknowledging that geopolitical developments may continue to create volatility in regional travel, freight and input costs, it said the underlying demand for private healthcare and medical tourism remains constructive.
“The group will continue to broaden its foreign patient source markets, referral channels and pay or partnerships, while maintaining diversified sourcing, adequate inventory buffers and disciplined cost management,” it said.
